| 摘要 |
<p>The present invention relates, in general to methods for treating degenerative cartilage in an individual comprising administering a composition that increases bone morphogenic protein (BMP) expression directly into injured or damaged cartilage, such as in a vertebral disc or a joint, wherein the composition is in a controlled release formulation.</p> |
